Cognition Therapeutics Announces Completion of Patient Enrollment for CT1812 Phase 2 Study in Dementia with Lewy Bodies
Apr 29, 2024
Enrollment Invest Information
Stride's Strong Fiscal Q2 2024 Earnings Bolstered by Enrollment Growth
Jan 25, 2024
Xilio Therapeutics Commences Phase 1 Trial for XTX101 in Combination Therapy for MSS CRC
Dec 7, 2023